The suspect in the German car-ramming attack that killed five and injured more than 200 on Friday has been identified as ...
"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity." ...
The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
There are many breakthroughs in medicine regarding the treatment of obstructive sleep apnea, and a weight loss drug might ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.